$2.48
0.072.90%
At close: -
$3.60
1.1245.16%
After Hours: Mar 26, 9:02 AM EDT
Comments
Loading...
Xenetic Biosciences Analyst Ratings and Price Targets | NASDAQ:XBIO | Benzinga
Xenetic Biosciences Inc has a consensus price target of - based on the ratings of 1 analysts. The high is issued by on . The low is issued by on . The 2 most-recent analyst ratings were released by HC Wainwright & Co. on April 11, 2023 and May 2, 2022, respectively. With an average price target of $4 between HC Wainwright & Co., there's an implied 61.29% upside for Xenetic Biosciences Inc from these most-recent analyst ratings.
Analyst Ratings for Xenetic Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/20/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Reiterates | Neutral → Neutral | Get Alert |
| 12/05/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Reiterates | Neutral → Neutral | Get Alert |
| 11/22/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Reiterates | → Neutral | Get Alert |
| 08/20/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Reiterates | → Neutral | Get Alert |
| 05/16/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis43% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2023 | Buy Now | 61.29% | HC Wainwright & Co. | Joseph Pantginis43% | → $40 | Reiterates | → Buy | Get Alert |
| 05/02/2022 | Buy Now | 61.29% | HC Wainwright & Co. | Joseph Pantginis43% | $50 → $40 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Xenetic Biosciences (XBIO) stock?
The latest price target for Xenetic Biosciences (NASDAQ:XBIO) was reported by HC Wainwright & Co. on April 9, 2025. The analyst firm set a price target for $0.00 expecting XBIO to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xenetic Biosciences (XBIO)?
The latest analyst rating for Xenetic Biosciences (NASDAQ:XBIO) was provided by HC Wainwright & Co., and Xenetic Biosciences reiterated their neutral rating.
When was the last upgrade for Xenetic Biosciences (XBIO)?
There is no last upgrade for Xenetic Biosciences
When was the last downgrade for Xenetic Biosciences (XBIO)?
The last downgrade for Xenetic Biosciences Inc happened on May 16, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Xenetic Biosciences Inc.
When is the next analyst rating going to be posted or updated for Xenetic Biosciences (XBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xenetic Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xenetic Biosciences was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating Xenetic Biosciences (XBIO) correct?
While ratings are subjective and will change, the latest Xenetic Biosciences (XBIO) rating was a reiterated with a price target of $0.00 to $0.00. The current price Xenetic Biosciences (XBIO) is trading at is $2.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.